Checkpoint Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CKPT and other ETFs, options, and stocks.

About CKPT

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. 

CEO
James F. Oliviero
CEOJames F. Oliviero
Employees
14
Employees14
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2014
Founded2014
Employees
14
Employees14

CKPT Key Statistics

Market cap
98.05M
Market cap98.05M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
264.74K
Average volume264.74K
High today
$1.06
High today$1.06
Low today
$1.02
Low today$1.02
Open price
$1.05
Open price$1.05
Volume
337.69K
Volume337.69K
52 Week high
$4.64
52 Week high$4.64
52 Week low
$0.96
52 Week low$0.96

CKPT Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3
ActualExpected Nov 3
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.